| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.93▼ | 9.28▼ | 8.92▼ | 8.29▲ | 8.23▲ |
| MA10 | 9.26▼ | 9.01▼ | 8.46▲ | 8.23▲ | 8.02▲ |
| MA20 | 9.32▼ | 8.50▲ | 8.26▲ | 8.23▲ | 9.06▼ |
| MA50 | 9.19▼ | 8.28▲ | 8.21▲ | 8.10▲ | 10.24▼ |
| MA100 | 8.59▲ | 8.22▲ | 8.17▲ | 9.32▼ | 12.66▼ |
| MA200 | 8.30▲ | 8.19▲ | 8.23▲ | 10.63▼ | 21.96▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.107▼ | 0.095▲ | 0.133▲ | 0.042▲ | 0.002▲ |
| RSI | 32.623▼ | 55.130▲ | 61.631▲ | 63.555▲ | 45.235▼ |
| STOCH | 20.319 | 83.945▲ | 66.525 | 52.318 | 47.503 |
| WILL %R | -91.573▼ | -47.661 | -47.661 | -47.278 | -54.218 |
| CCI | -140.526▼ | 39.132 | 104.290▲ | 383.319▲ | 36.870 |
| ▲ PSAR&MOM | $ARVN PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&MACD | $ARVN MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $ARVN RSI Cross Up and Volume | Set Alert |
| RSI | $ARVN RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $ARVN MACD(12,26,9) Crossed Above Zero | Set Alert |
| ▲ MACD | $ARVN MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $ARVN Price Crossed Above MA(50) | Set Alert |
| MA | $ARVN Price Crossed Above MA(26) | Set Alert |
| MA | $ARVN Price Crossed Above MA(13) | Set Alert |
| MA | $ARVN Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $ARVN Open Gap Up %3 | Set Alert |
| ▲ GAP | $ARVN Open Gap Up %2 | Set Alert |
| ▲ BREAK | $ARVN Price Breaks 10 Days High | Set Alert |
|
Tuesday, July 28, 2026 12:00 AM
Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review second quarter 2026 financial ...
|
|
Sunday, December 21, 2025 04:00 PM
As of December 22, 2025, the average one-year price target for Arvinas is $13.20/share. The forecasts range from a low of $6.06 to a high of $22.05. The average price target represents an increase of ...
|
|
Sunday, August 17, 2025 04:41 PM
Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc. (NYSE:PFE), announced that the US FDA accepted its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/08/26 | 8.46 | 9.64 | 8.46 | 8.815 | 1,975,582 |
| 03/08/26 | 8.10 | 8.10 | 7.92 | 8.06 | 706,620 |
| 31/07/26 | 8.24 | 8.24 | 7.895 | 8.03 | 655,746 |
| 30/07/26 | 8.11 | 8.305 | 8.10 | 8.30 | 523,949 |
| 29/07/26 | 8.18 | 8.34 | 8.09 | 8.22 | 725,808 |
| 28/07/26 | 8.24 | 8.32 | 8.02 | 8.20 | 536,856 |
| 27/07/26 | 8.13 | 8.37 | 8.12 | 8.22 | 457,712 |
| 24/07/26 | 8.11 | 8.16 | 7.95 | 8.03 | 356,414 |
| 23/07/26 | 8.14 | 8.31 | 8.04 | 8.12 | 704,976 |
| 22/07/26 | 8.21 | 8.40 | 8.15 | 8.26 | 582,413 |
|
|
||||
|
|
||||
|
|